Annovis Bio, Inc. (ANVS) Financials
ANVS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 10.2 million | 3.6 million |
2023-06-30 | 22.8 million | 2.1 million |
2023-03-31 | 25.5 million | 5.4 million |
2022-12-31 | 36.0 million | 7.7 million |
ANVS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.4 million | 632191 |
2023-06-30 | -9.6 million | 1.6 million |
2023-03-31 | -11.6 million | 1.5 million |
2022-12-31 | -3.6 million | 1.5 million |
ANVS Net Income
No data available :(
ANVS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 6.4 million | - | - |
2023-06-30 | 15.7 million | - | - |
2023-03-31 | 16.8 million | - | - |
2022-12-31 | 28.4 million | - | - |
ANVS Shares Outstanding
ANVS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 13.8 million | 1.0 million | - |
2023-06-30 | - | 8.3 million | 1.5 million | - |
2023-03-31 | - | 7.8 million | 2.2 million | - |
2022-12-31 | - | 1.6 million | 1.6 million | - |
ANVS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 13.8 million |
2023-06-30 | - | 8.3 million |
2023-03-31 | - | 7.8 million |
2022-12-31 | - | 1.6 million |
ANVS
Price: $18.01
52 week price:
Earnings Per Share: -6.23 USD
P/E Ratio: -2.06
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 103127
Market Capitalization: 128.1 million